Repetitive Mild Traumatic Brain Injury-induced Neurodegeneration and Inflammation is Attenuated by Acetyl-L-carnitine in a Preclinical Model

Overview

Journal Front Pharmacol

Date 2023 Sep 25

PMID 37745053

Authors

Matthew I Hiskens

Katy M Li

Anthony G Schneiders

Andrew S Fenning

Affiliations

Soon will be listed here.

Abstract

Repetitive mild traumatic brain injuries (rmTBI) may contribute to the development of neurodegenerative diseases through secondary injury pathways. Acetyl-L-carnitine (ALC) shows neuroprotection through anti-inflammatory effects and via regulation of neuronal synaptic plasticity by counteracting post-trauma excitotoxicity. This study aimed to investigate mechanisms implicated in the etiology of neurodegeneration in rmTBI mice treated with ALC. Adult male C57BL/6J mice were allocated to sham, rmTBI or ALC + rmTBI groups. 15 rmTBIs were administered across 23 days using a modified weight drop model. Neurological testing and spatial learning and memory assessments via the Morris Water Maze (MWM) were undertaken at 48 h and 3 months. RT-PCR analysis of the cortex and hippocampus was undertaken for MAPT, GFAP, AIF1, GRIA, CCL11, TDP43, and TNF genes. Gene expression in the cortex showed elevated mRNA levels of MAPT, TNF, and GFAP in the rmTBI group that were reduced by ALC treatment. In the hippocampus, mRNA expression was elevated for GRIA1 in the rmTBI group but not the ALC + rmTBI treatment group. ALC treatment showed protective effects against the deficits displayed in neurological testing and MWM assessment observed in the rmTBI group. While brain structures display differential vulnerability to insult as evidenced by location specific postimpact disruption of key genes, this study shows correlative mRNA neurodegeneration and functional impairment that was ameliorated by ALC treatment in several key genes. ALC may mitigate damage inflicted in the various secondary neurodegenerative cascades and contribute to functional protection following rmTBI.

Citing Articles

L-carnitine ameliorates myocardial injury by alleviating endoplasmic reticulum stress via inhibition of PERK pathway in exertional heatstroke rats.

Zhang B, He G, Wang Z, Zhou H, Huang X, Shen T Heliyon. 2024; 10(22):e40502.

PMID: 39641050 PMC: 11617224. DOI: 10.1016/j.heliyon.2024.e40502.

Circulating medium- and long-chain acylcarnitines are associated with plasma P-tau181 in cognitively normal older adults.

Sharmin T, Chatterjee P, Doecke J, Ashton N, Huynh K, Pedrini S J Neurochem. 2024; 169(2).

PMID: 39473263 PMC: 11808462. DOI: 10.1111/jnc.16244.

Metabolic reprogramming: a new option for the treatment of spinal cord injury.

Chen J, Chen J, Yu C, Xia K, Yang B, Wang R Neural Regen Res. 2024; 20(4):1042-1057.

PMID: 38989936 PMC: 11438339. DOI: 10.4103/NRR.NRR-D-23-01604.

Innovative Insights into Traumatic Brain Injuries: Biomarkers and New Pharmacological Targets.

Silvestro S, Raffaele I, Quartarone A, Mazzon E Int J Mol Sci. 2024; 25(4).

PMID: 38397046 PMC: 10889179. DOI: 10.3390/ijms25042372.

References

Montenigro P, Alosco M, Martin B, Daneshvar D, Mez J, Chaisson C . Cumulative Head Impact Exposure Predicts Later-Life Depression, Apathy, Executive Dysfunction, and Cognitive Impairment in Former High School and College Football Players. J Neurotrauma. 2016; 34(2):328-340. PMC: 5220530. DOI: 10.1089/neu.2016.4413. View

Bigford G, Del Rossi G . Supplemental substances derived from foods as adjunctive therapeutic agents for treatment of neurodegenerative diseases and disorders. Adv Nutr. 2014; 5(4):394-403. PMC: 4085188. DOI: 10.3945/an.113.005264. View

Vorhees C, Williams M . Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc. 2007; 1(2):848-58. PMC: 2895266. DOI: 10.1038/nprot.2006.116. View

Castorina M, Ambrosini A, Pacific L, Ramacci M, Angelucci L . Age-dependent loss of NMDA receptors in hippocampus, striatum, and frontal cortex of the rat: prevention by acetyl-L-carnitine. Neurochem Res. 1994; 19(7):795-8. DOI: 10.1007/BF00967446. View

Bagetta V, Barone I, Ghiglieri V, Di Filippo M, Sgobio C, Bernardi G . Acetyl-L-Carnitine selectively prevents post-ischemic LTP via a possible action on mitochondrial energy metabolism. Neuropharmacology. 2008; 55(2):223-9. DOI: 10.1016/j.neuropharm.2008.05.015. View

Malaguarnera M . Carnitine derivatives: clinical usefulness. Curr Opin Gastroenterol. 2012; 28(2):166-76. DOI: 10.1097/MOG.0b013e3283505a3b. View

Mahmoodpoor A, Shokouhi G, Hamishehkar H, Soleimanpour H, Sanaie S, Porhomayon J . A pilot trial of l-carnitine in patients with traumatic brain injury: Effects on biomarkers of injury. J Crit Care. 2018; 45:128-132. DOI: 10.1016/j.jcrc.2018.01.029. View

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

Piovesan P, Pacifici L, Taglialatela G, Ramacci M, Angelucci L . Acetyl-L-carnitine treatment increases choline acetyltransferase activity and NGF levels in the CNS of adult rats following total fimbria-fornix transection. Brain Res. 1994; 633(1-2):77-82. DOI: 10.1016/0006-8993(94)91524-5. View

10.

Parajuli B, Horiuchi H, Mizuno T, Takeuchi H, Suzumura A . CCL11 enhances excitotoxic neuronal death by producing reactive oxygen species in microglia. Glia. 2015; 63(12):2274-84. DOI: 10.1002/glia.22892. View

11.

Cherry J, Stein T, Tripodis Y, Alvarez V, Huber B, Au R . CCL11 is increased in the CNS in chronic traumatic encephalopathy but not in Alzheimer's disease. PLoS One. 2017; 12(9):e0185541. PMC: 5614644. DOI: 10.1371/journal.pone.0185541. View

12.

Babu G, Kumar A, Singh R . Chronic pretreatment with acetyl-L-carnitine and ±DL-α-lipoic acid protects against acute glutamate-induced neurotoxicity in rat brain by altering mitochondrial function. Neurotox Res. 2010; 19(2):319-29. DOI: 10.1007/s12640-010-9165-3. View

13.

Cherry J, Tripodis Y, Alvarez V, Huber B, Kiernan P, Daneshvar D . Microglial neuroinflammation contributes to tau accumulation in chronic traumatic encephalopathy. Acta Neuropathol Commun. 2016; 4(1):112. PMC: 5084333. DOI: 10.1186/s40478-016-0382-8. View

14.

Burks S, Raymick J, Robinson B, Hanig J, Sarkar S . Neuroprotective effects of acetyl-l-carnitine (ALC) in a chronic MPTP-induced Parkinson's disease mouse model: Endothelial and microglial effects. Neurosci Lett. 2019; 703:86-95. DOI: 10.1016/j.neulet.2019.03.015. View

15.

Corps K, Roth T, McGavern D . Inflammation and neuroprotection in traumatic brain injury. JAMA Neurol. 2015; 72(3):355-62. PMC: 5001842. DOI: 10.1001/jamaneurol.2014.3558. View

16.

Sandhir R, Onyszchuk G, Berman N . Exacerbated glial response in the aged mouse hippocampus following controlled cortical impact injury. Exp Neurol. 2008; 213(2):372-80. PMC: 2662478. DOI: 10.1016/j.expneurol.2008.06.013. View

17.

Singh S, Mishra A, Srivastava N, Shukla R, Shukla S . Acetyl-L-Carnitine via Upegulating Dopamine D1 Receptor and Attenuating Microglial Activation Prevents Neuronal Loss and Improves Memory Functions in Parkinsonian Rats. Mol Neurobiol. 2016; 55(1):583-602. DOI: 10.1007/s12035-016-0293-5. View

18.

Calabrese V, Scapagnini G, Ravagna A, Bella R, Butterfield D, Calvani M . Disruption of thiol homeostasis and nitrosative stress in the cerebrospinal fluid of patients with active multiple sclerosis: evidence for a protective role of acetylcarnitine. Neurochem Res. 2003; 28(9):1321-8. DOI: 10.1023/a:1024984013069. View

19.

Yin Y, Liu H, Cong X, Liu Z, Wang Q, Wang J . Acetyl-L-carnitine attenuates okadaic acid induced tau hyperphosphorylation and spatial memory impairment in rats. J Alzheimers Dis. 2010; 19(2):735-46. DOI: 10.3233/JAD-2010-1272. View

20.

Jones L, McDonald D, Borum P . Acylcarnitines: role in brain. Prog Lipid Res. 2009; 49(1):61-75. DOI: 10.1016/j.plipres.2009.08.004. View